National Bank of Canada’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
1,084,578
+712,978
| +192% | +$884K | ﹤0.01% | 991 |
|
|
2025
Q1 | $438K | Buy |
+371,600
| New | +$438K | ﹤0.01% | 1101 |
|
|
2024
Q3 | – | Sell |
-2,000
| Closed | -$2.38K | – | 2753 |
|
|
2024
Q2 | $2.38K | Hold |
2,000
| – | – | ﹤0.01% | 2245 |
|
|
2024
Q1 | $3.54K | Hold |
2,000
| – | – | ﹤0.01% | 2182 |
|
|
2023
Q4 | $19.2K | Hold |
2,000
| – | – | ﹤0.01% | 1852 |
|
|
2023
Q3 | $16.1K | Hold |
2,000
| – | – | ﹤0.01% | 1865 |
|
|
2023
Q2 | $26.6K | Hold |
2,000
| – | – | ﹤0.01% | 1771 |
|
|
2023
Q1 | $23.1K | Hold |
2,000
| – | – | ﹤0.01% | 1790 |
|
|
2022
Q4 | $16.3K | Sell |
2,000
-4,000
| -67% | -$32.7K | ﹤0.01% | 1894 |
|
|
2022
Q3 | $35K | Buy |
6,000
+3,400
| +131% | +$19.8K | ﹤0.01% | 1655 |
|
|
2022
Q2 | $12K | Buy |
2,600
+1,960
| +306% | +$9.05K | ﹤0.01% | 2011 |
|
|
2022
Q1 | $6K | Hold |
640
| – | – | ﹤0.01% | 2275 |
|
|
2021
Q4 | $13K | Buy |
+640
| New | +$13K | ﹤0.01% | 2052 |
|